PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$78.06M
Total Shares
18.67M
Net Share Change
-7.79M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Patient Capital Management
$78.06M18.67M shares
TRIM-7.79M(-29.4%)